Stay updated on Pembrolizumab in Advanced Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Sarcomas Clinical Trial page
- Check3 days agoChange DetectedThe page’s footer software/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site build update rather than a change to the study record content.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision: v3.4.3 applied, replacing v3.4.2.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page now shows a minor version update: v3.4.2 added and v3.4.1 removed, with no changes to study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedThe University of Texas MD Anderson Cancer Center is renamed to M.D. Anderson Cancer Center in the locations list, and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Advanced Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.